An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samples

Marlene Thomas1, Manuela Poignée-Heger, Martin Weisser

  • 1Pharma Research and Early Development (pRED), Roche Diagnostics GmbH, TR-H, Bldg 231/206a, Nonnenwald 2, 82377 Penzberg, Germany. marlene.thomas@roche.com.

Summary

A new workflow for formalin-fixed, paraffin-embedded tissue (FFPET) enables gene expression profiling, improving biomarker discovery for cancer. This method enhances detection sensitivity using FFPET samples, crucial for advancing cancer research.

Related Concept Videos